# Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years

> **NCT00353184** · NA · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 27 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Montelukast 5-mg orally added to standard therapy

## Key facts

- **NCT ID:** NCT00353184
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-09
- **Primary completion:** 2004-10
- **Final completion:** 2005-02
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Results of the interim analysis suggested no significant diff between study groups.
- **Last updated:** 2010-02-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00353184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00353184, "Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00353184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*